NADPH oxidase: recent evidence for its role in erectile dysfunction

Area of Science:

• Physiology and Pathophysiology
• Molecular Biology
• Urology

Background:

• Reactive oxygen species (ROS) are increasingly recognized for their critical roles in both normal physiological processes and disease states.
• While ROS function as signaling molecules in cellular regulation under normal conditions, their overproduction is implicated in the pathogenesis of various diseases, particularly vascular diseases.
• Increased ROS levels are associated with erectile dysfunction (ED), but the specific sources of ROS within the penis are not fully understood.

Purpose of the Study:

• To review the relationship between ROS and erectile dysfunction (ED) across different disease models.
• To examine the emerging evidence implicating NADPH oxidase (NOX) as a significant source of ROS contributing to ED.
• To discuss the current evidence supporting the role of NADPH oxidase-derived ROS in the development of ED.

Main Methods:

• Literature review of existing studies on ROS, NADPH oxidase, and erectile dysfunction.
• Analysis of data from various disease models investigating the mechanisms of ED.
• Synthesis of evidence connecting ROS production, particularly from NADPH oxidase, to penile pathophysiology.

Main Results:

• Enhanced ROS production, often linked to NADPH oxidase activation, is a significant factor in vascular disease pathogenesis.
• Emerging evidence points towards NADPH oxidase as a key contributor to the development of erectile dysfunction.
• The review consolidates findings from diverse disease models, highlighting the consistent association between ROS and ED.

Conclusions:

• NADPH oxidase is a likely major source of ROS implicated in the pathophysiology of erectile dysfunction.
• Targeting NADPH oxidase-derived ROS presents a potential therapeutic strategy for managing erectile dysfunction.
• Further research is warranted to fully elucidate the mechanisms by which NADPH oxidase contributes to ED.